Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred

SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

See all formats and pricing



Select Volume and Issue
Loading journal volume and issue information...

A stable analogue of glucose-dependent insulinotropic polypeptide, GIP(LysPAL16), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones

Lamin Marenah1 / Jane T. McCluskey2 / Yasser H.A. Abdel-Wahab3 / Finbarr P.M. O'Harte4 / Neville H. McClenaghan5 / Peter R. Flatt6







Corresponding author

Citation Information: Biological Chemistry. Volume 387, Issue 7, Pages 941–947, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2006.118, July 2006

Publication History

December 15, 2005
March 20, 2006
Published Online:


Embryonic stem (ES) cells can be differentiated into insulin-producing cells by conditioning the culture media. However, the number of insulin-expressing cells and amount of insulin released is very low. Glucose-dependent insulinotropic polypeptide (GIP) enhances the growth and differentiation of pancreatic β-cells. This study examined the potential of the stable analogue GIP(LysPAL16) to enhance the differentiation of mouse ES cells into insulin-producing cells using a five-stage culturing strategy. Semi-quantitative PCR indicated mRNA expression of islet development markers (nestin, Pdx1, Nkx6.1, Oct4), mature pancreatic β-cell markers (insulin, glucagon, Glut2, Sur1, Kir6.1) and the GIP receptor gene GIP-R in undifferentiated (stage 1) cells, with increasing levels in differentiated stages 4 and 5. IAPP and somatostatin genes were only expressed in differentiated stages. Immunohistochemical studies confirmed the presence of insulin, glucagon, somatostatin and IAPP in differentiated ES cells. After supplementation with GIP(LysPAL16), ES cells at stage 4 released insulin in response to secretagogues and glucose in a concentration-dependent manner, with 35–100% increases in insulin release. Cellular C-peptide content also increased by 45% at stages 4 and 5. We conclude that the stable GIP analogue enhanced differentiation of mouse ES cells towards a phenotype expressing specific β-cell genes and releasing insulin.

Keywords: embryonic stem cells; GIP; insulin-releasing cells

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Insa S. Schroeder
Current Diabetes Reports, 2012, Volume 12, Number 5, Page 490
Ping Lü, Fang Liu, Lei Yan, Tao Peng, Tao Liu, Zhong Yao, and Chun-You Wang
Diabetes Research and Clinical Practice, 2007, Volume 78, Number 1, Page 1
Brian D. Green and Peter R. Flatt
Best Practice & Research Clinical Endocrinology & Metabolism, 2007, Volume 21, Number 4, Page 497
George K. Gittes
Developmental Biology, 2009, Volume 326, Number 1, Page 4
Catriona Kelly, Cara C. S. Flatt, and Neville H. McClenaghan
Stem Cells International, 2011, Volume 2011, Page 1
Nigel Irwin and Peter R. Flatt
Best Practice & Research Clinical Endocrinology & Metabolism, 2009, Volume 23, Number 4, Page 499
Jeremy A. Lavine and Alan D. Attie
Annals of the New York Academy of Sciences, 2010, Volume 1212, Number 1, Page 41
Dieter Hoersch and Joerg Schrader
AfCS-Nature Molecule Pages, 2007
Sabine Sulzbacher, Insa S. Schroeder, Thuy T. Truong, and Anna M. Wobus
Stem Cell Reviews and Reports, 2009, Volume 5, Number 2, Page 159
Victor A. Gault, Paula L. McClean, Nigel Irwin, Gavin J. Power, Janie T. McCluskey, and Peter R. Flatt
Pancreas, 2007, Volume 35, Number 1, Page 73

Comments (0)

Please log in or register to comment.